- Home
- SNTI vs MAMO Comparison
SNTI vs MAMO Comparison
Compare SNTI & MAMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNTI
- MAMO
- Stock Information
- Founded
- SNTI 2016
- MAMO 2008
- Country
- SNTI United States
- MAMO United States
- Employees
- SNTI N/A
- MAMO N/A
- Industry
- SNTI Biotechnology: Pharmaceutical Preparations
- MAMO
- Sector
- SNTI Health Care
- MAMO
- Exchange
- SNTI Nasdaq
- MAMO NYSE
- Market Cap
- SNTI 85.3M
- MAMO 91.0M
- IPO Year
- SNTI N/A
- MAMO 2024
- Fundamental
- Price
- SNTI $2.26
- MAMO $2.79
- Analyst Decision
- SNTI Strong Buy
- MAMO
- Analyst Count
- SNTI 2
- MAMO 0
- Target Price
- SNTI $8.50
- MAMO N/A
- AVG Volume (30 Days)
- SNTI 385.8K
- MAMO 28.4K
- Earning Date
- SNTI 08-12-2025
- MAMO 08-11-2025
- Dividend Yield
- SNTI N/A
- MAMO N/A
- EPS Growth
- SNTI N/A
- MAMO N/A
- EPS
- SNTI N/A
- MAMO N/A
- Revenue
- SNTI N/A
- MAMO $95,959,187.00
- Revenue This Year
- SNTI N/A
- MAMO N/A
- Revenue Next Year
- SNTI $150.00
- MAMO N/A
- P/E Ratio
- SNTI N/A
- MAMO N/A
- Revenue Growth
- SNTI N/A
- MAMO N/A
- 52 Week Low
- SNTI $1.52
- MAMO $1.84
- 52 Week High
- SNTI $16.94
- MAMO $4.66
- Technical
- Relative Strength Index (RSI)
- SNTI 37.88
- MAMO N/A
- Support Level
- SNTI $2.05
- MAMO N/A
- Resistance Level
- SNTI $2.35
- MAMO N/A
- Average True Range (ATR)
- SNTI 0.30
- MAMO 0.00
- MACD
- SNTI 0.00
- MAMO 0.00
- Stochastic Oscillator
- SNTI 20.00
- MAMO 0.00
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.
About MAMO MASSIMO GROUP
Massimo Group is engaged in the mid-tier band the (Mid-Tier Band) of the Powersports Vehicles and Boats Industry. It manufacture, import and distribute a diversified portfolio of products divided into two main lines: a motor sports brand consisting of utility terrain vehicles (UTVs), all-terrain vehicles (ATVs), motorcycles, scooters, golf carts, and a juvenile line from go karts to balance bikes; and a motor boat line consisting of pontoon and tritoon boats (Pontoon Boats).